Amygdala and regional volumes in treatment-resistant versus nontreatment-resistant depression patients

作者：Sandu Anca Larisa^*; Artiges Eric; Galinowski Andre; Gallarda Thierry; Bellivier Frank; Lemaitre Herve; Granger Bernard; Ringuenet Damien; Tzavara Eleni T; Martinot Jean Luc; Martinot Marie Laure Paillere

来源：Depression and Anxiety, 2017, 34(11): 1065-1071.

DOI：10.1002/da.22675

• biological markers
• bipolar disorder
• brain imaging
• neuroimaging
• depression
• treatment resistance

BackgroundAlthough treatment-resistant and nontreatment-resistant depressed patients show structural brain anomalies relative to healthy controls, the difference in regional volumetry between these two groups remains undocumented.
MethodsA whole-brain voxel-based morphometry (VBM) analysis of regional volumes was performed in 125 participants' magnetic resonance images obtained on a 1.5 Tesla scanner; 41 had treatment-resistant depression (TRD), 40 nontreatment-resistant depression (non-TRD), and 44 were healthy controls. The groups were comparable for age and gender. Bipolar/unipolar features as well as pharmacological treatment classes were taken into account as covariates.
ResultsTRD patients had higher gray matter (GM) volume in the left and right amygdala than non-TRD patients. No difference was found between the TRD bipolar and the TRD unipolar patients, or between the non-TRD bipolar and non-TRD unipolar patients. An exploratory analysis showed that lithium-treated patients in both groups had higher GM volume in the superior and middle frontal gyri in both hemispheres.
ConclusionsHigher GM volume in amygdala detected in TRD patients might be seen in perspective with vulnerability to chronicity, revealed by medication resistance.

• 出版日期2017-11